E-viri
Recenzirano
Odprti dostop
-
Domínguez‐Carral, Jana; Ludlam, William Grant; Junyent Segarra, Mar; Fornaguera Marti, Montserrat; Balsells, Sol; Muchart, Jordi; Čokolić Petrović, Dunja; Espinoza, Iván; Ortigoza‐Escobar, Juan Dario; Martemyanov, Kirill A.; Armstrong, Judith; Blanco‐Lago, Raquel; Bou, Rosa; Cáceres‐Marzal, Cristina; Cancho‐Candela, Ramón; Candela, Santiago; Darling, Alejandra; Los Santos, Mariela Mercedes; García‐Cazorla, Angels; Martí‐Carrera, Itxaso; Martorell, Loreto; Mateos Checa, Rosario; Meavilla, Silvia; Mínguez Rodríguez, Beatriz; Pantoja, Jorge; Pías, Leticia; Parra Plantagenet‐Whyte, Fátima; Pinillos, Sergio; Ruiz‐Hernández, Carlos José; Rumià, Jordi; Caballero Pérez, Victoria; Salvador Cañibano, Maria; Yubero, Delia
Annals of neurology, November 2023, Letnik: 94, Številka: 5Journal Article
Objective GNAO1‐related disorders (OMIM #615473 and #617493), caused by variants in the GNAO1 gene, are characterized by developmental delay or intellectual disability, hypotonia, movement disorders, and epilepsy. Neither a genotype–phenotype correlation nor a clear severity score have been established for this disorder. The objective of this prospective and retrospective observational study was to develop a severity score for GNAO1‐related disorders, and to delineate the correlation between the underlying molecular mechanisms and clinical severity. Methods A total of 16 individuals with GNAO1‐related disorders harboring 12 distinct missense variants, including four novel variants (p.K46R, p.T48I, p.R209P, and p.L235P), were examined with repeated clinical assessments, video‐electroencephalogram monitoring, and brain magnetic resonance imaging. The molecular pathology of each variant was delineated using a molecular deconvoluting platform. Results The patients displayed a wide variability in the severity of their symptoms. This heterogeneity was well represented in the GNAO1‐related disorders severity score, with a broad range of results. Patients with the same variant had comparable severity scores, indicating that differences in disease profiles are not due to interpatient variability, but rather, to unique disease mechanisms. Moreover, we found a significant correlation between clinical severity scores and molecular mechanisms. Interpretation The clinical score proposed here provides further insight into the correlation between pathophysiology and phenotypic severity in GNAO1‐related disorders. We found that each variant has a unique profile of clinical phenotypes and pathological molecular mechanisms. These findings will contribute to better understanding GNAO1‐related disorders. Additionally, the severity score will facilitate standardization of patients categorization and assessment of response to therapies in development. ANN NEUROL 2023;94:987–1004
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.